博文
新型免疫疗法有望治疗多发性骨髓瘤
||
新型免疫疗法有望治疗多发性骨髓瘤
https://www.ebiotrade.com/newsf/2024-2/20240215044755463.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=757aa4d1-38f4-43f7-8dd9-559e6d6e6be9
| 01. | Humans | 5 篇 | 83.333% |
| 02. | Immunotherapy, Adoptive | 5 篇 | 83.333% |
| 03. | Receptors, Chimeric Antigen | 4 篇 | 66.667% |
| 04. | T-Lymphocytes | 3 篇 | 50.000% |
| 05. | Hematopoietic Stem Cell Transplantation | 2 篇 | 33.333% |
| 06. | Acute Disease | 1 篇 | 16.667% |
| 07. | Adult | 1 篇 | 16.667% |
| 08. | Animals | 1 篇 | 16.667% |
| 09. | Antibodies | 1 篇 | 16.667% |
| 10. | B-Cell Maturation Antigen | 1 篇 | 16.667% |
https://kns.cnki.net/kns8s/search?classid=WD0FTY92&kw=CAR-T%E7%BB%86%E8%83%9E&korder=SU
https://fx.wanfangdata.com.cn/keytrends/detail?theme_name=CAR-T%E7%BB%86%E8%83%9E
(506)
(202)
(61)
(40)
(40)
(39)
(36)
(35)
(33)
(28)
https://fx.wanfangdata.com.cn/keytrends/detail?theme_name=CAR-T%E7%BB%86%E8%83%9E
https://blog.sciencenet.cn/blog-280034-1422305.html
上一篇：长期记忆研究热点 Nature：斯坦福著名学者解析与长期记忆有关的细胞类型
下一篇：GPCR之谜:新研究揭示了一个关键药物靶点功能的分子起源
